Page last updated: 2024-10-26

brl 42810 and Hepatitis C, Chronic

brl 42810 has been researched along with Hepatitis C, Chronic in 3 studies

Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Research Excerpts

ExcerptRelevanceReference
"Due to its low efficacy, 40% in the treatment of chronic hepatitis B and 10-20% in the treatment of chronic hepatitis C, and to its adverse events, in some cases severe, new antiviric molecules are being investigated."2.40[New antiviral agents in the treatment of chronic hepatitis B and C]. ( Córdoba Cortijo, J; López Viedma, B; Olaso Peiró, V, 1998)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olaso Peiró, V1
López Viedma, B1
Córdoba Cortijo, J1
Main, J1
McCarron, B1
Thomas, HC1
Zavaglia, C1
Airoldi, A1
Pinzello, G1

Reviews

3 reviews available for brl 42810 and Hepatitis C, Chronic

ArticleYear
[New antiviral agents in the treatment of chronic hepatitis B and C].
    Revista espanola de enfermedades digestivas, 1998, Volume: 90, Issue:4

    Topics: 2-Aminopurine; Antimetabolites; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B

1998
Treatment of chronic viral hepatitis.
    Antiviral chemistry & chemotherapy, 1998, Volume: 9, Issue:6

    Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models

1998
Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
    Journal of clinical gastroenterology, 2000, Volume: 30, Issue:3

    Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic

2000